PURPOSE To evaluate the efficacy of the Advance® and AdvanceXP® slings in men with stress urinary incontinence (SUI) post-radical prostatectomy and to identify predictive factors for outcome. METHODS Included were male patients with SUI following radical prostatectomy who had a positive "repositioning test", 24 h-pad weight (PW) test < 400 g and who were continent at night and at rest. Urgency was defined as a sudden compelling desire to pass urine, which was difficult to defer. The cure rate was defined as no pad use. RESULTS From February 2008 to October 2014, 24 AdVance® and 70 AdVance XP® were implanted. The median (range) follow-up was 49 (12-102) months. The overall cure rate was 77%. The preoperative 24 h PW was significantly related to the continence outcome (p = 0.044). A total of 12 patients (13%) presented with postoperative AUR, which was significantly related to abnormal voiding detrusor activity (p = 0.036). Twenty-two patients (23%) had postoperative urgency (16% "de novo"), which was significantly related to preoperative urgency (p = 0.003). During follow-up, a degree of deterioration of continence was observed in five patients who were classed as cured initially. To date, no reports of urethral sling erosion have been made. CONCLUSIONS The AdVance® and AdVanceXP® slings are safe and effective in relieving SUI following post-radical prostatectomy. There were no differences between the two slings in terms of efficacy, urgency or postoperative AUR. There was a moderate rate of "de novo "urgency and low rate of loss of continence during follow-up.

中文翻译：

---

Advance®和AdvanceXP®男性吊带手术后的功能随访：评估预测因素。

目的评估Progress®和AdvanceXP®吊索在根治性前列腺切除术后压力性尿失禁（SUI）男性中的疗效，并确定预后的预测因素。方法包括前列腺癌根治术后SUI的男性患者，其“重新定位试验”阳性，24 h-pad重量（PW）试验<400 g，且在夜间和休息时均为大陆。紧急情况被定义为突然迫切需要通过尿液，这很难推迟。治愈率定义为不使用护垫。结果从2008年2月至2014年10月，植入了24枚AdVance®和70枚AdVanceXP®。中位（范围）随访为49（12-102）个月。总体治愈率为77％。术前24 h PW与尿量结局显着相关（p = 0.044）。共有12例患者（13％）出现术后AUR，这与异常排尿逼尿肌活动显着相关（p = 0.036）。22名患者（23％）有术后尿急（16％“从头开始”），这与术前尿急显着相关（p = 0.003）。在随访期间，在最初被归类为治愈的五名患者中观察到了节制程度的恶化。迄今为止，还没有尿道吊带侵蚀的报道。结论AdVance®和AdVanceXP®吊带在根治性前列腺切除术后安全有效地缓解SUI。两种吊带在功效，紧迫性或术后AUR方面无差异。随访期间出现“新生”的急症发生率中等，失禁率低。这与异常排尿逼尿肌活动异常显着相关（p = 0.036）。22名患者（23％）有术后尿急（16％“从头开始”），这与术前尿急显着相关（p = 0.003）。在随访期间，在最初被归类为治愈的五名患者中观察到了节制程度的恶化。迄今为止，还没有尿道吊带侵蚀的报道。结论AdVance®和AdVanceXP®吊带在根治性前列腺切除术后安全有效地缓解SUI。两种吊带在功效，紧迫性或术后AUR方面无差异。随访期间出现“新生”的急症发生率中等，失禁率低。这与异常排尿逼尿肌活性显着相关（p = 0.036）。22名患者（23％）有术后尿急（16％“从头开始”），这与术前尿急显着相关（p = 0.003）。在随访期间，在最初被归类为治愈的五名患者中观察到了节制程度的恶化。迄今为止，还没有尿道吊带侵蚀的报道。结论AdVance®和AdVanceXP®吊带在根治性前列腺切除术后安全有效地缓解SUI。两种吊带在功效，紧迫性或术后AUR方面无差异。随访期间出现“新生”的急症发生率中等，失禁率低。22名患者（23％）有术后尿急（16％“从头开始”），这与术前尿急显着相关（p = 0.003）。在随访期间，在最初被归类为治愈的五名患者中观察到了节制程度的恶化。迄今为止，还没有尿道吊带侵蚀的报道。结论AdVance®和AdVanceXP®吊带在根治性前列腺切除术后安全有效地缓解SUI。两种吊带在功效，紧迫性或术后AUR方面无差异。随访期间出现“新生”的急症发生率中等，失禁率低。22名患者（23％）有术后尿急（16％“从头开始”），这与术前尿急显着相关（p = 0.003）。在随访期间，在最初被归类为治愈的五名患者中观察到了节制程度的恶化。迄今为止，还没有尿道吊带侵蚀的报道。结论AdVance®和AdVanceXP®吊带在根治性前列腺切除术后安全有效地缓解SUI。两种吊带在功效，紧迫性或术后AUR方面无差异。随访期间出现“新生”的急症发生率中等，失禁率低。在最初归类为治愈的五名患者中观察到一定程度的尿失禁。迄今为止，还没有尿道吊带侵蚀的报道。结论AdVance®和AdVanceXP®吊带在根治性前列腺切除术后安全有效地缓解SUI。两种吊带在功效，紧迫性或术后AUR方面无差异。随访期间出现“新生”的急症发生率中等，失禁率低。在最初归类为治愈的五名患者中观察到一定程度的尿失禁。迄今为止，还没有尿道吊带侵蚀的报道。结论AdVance®和AdVanceXP®吊带在根治性前列腺切除术后安全有效地缓解SUI。两种吊带在功效，紧迫性或术后AUR方面无差异。随访期间出现“新生”的急症发生率中等，失禁率低。